Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DPZ | FDS |
|---|---|---|
| Price | $297.27 | $276.44 |
| Change today | ▼ 0.12% | ▲ 3.92% |
| Market cap | $9.83B | $9.83B |
| Return, 3 months | -4.5% | +7.4% |
| Return, year to date | -27.4% | -3.4% |
| Return, 1 year | -28.2% | +2.3% |
| P/E (TTM) | 16.9 | 19.0 |
| P/B | -2.5 | 4.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.51% | 1.64% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 40 | 50 |
| 30-day volatility | 34.3% | 46.5% |
| Max drawdown, 1 year | -34.7% | -36.0% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
